The quantification of brain lesions with anω 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration

Previous investigations have indicated that the detection and quantification of omega 3 (peripheral type benzodiazepine) binding site densities that are associated with reactive astroglia and macrophages could be of widespread applicability in the localization and indirect assessment of neural tissue damage in the central nervous system. In the present study, we analyze the usefulness of this approach in a number of experimental models that are characterized by (or putatively involve) neuronal degeneration. One week after the systemic administration of the excitotoxin, kainate, a marked increase in omega 3 site densities (as assessed by [3H]PK 11195 binding) was noted, an increase that was most prominent in known regions of selective vulnerability (hippocampus and septum). However, the kainate-induced omega 3 site proliferation was not a function of the dose administered, a marked interstudy variation was observed, and the binding increase was prevented by the administration of the anticonvulsant, clonazepam. The densities of omega 3 sites were studied, by autoradiography (using [3H]PK 11195 or [3H]PK 14105 as ligands), in 4 groups of Fischer 344 rats aged 3, 12, 22 and 30 months. No age-related changes were noted except in the 30-month-old group in which discrete and focal increases (reflecting tumoral processes) were observed in various brain regions. In spontaneously hypertensive, stroke-prone rats, omega 3 binding increases were observed concomitant with the development of stroke-related neurological signs. With autoradiography, the omega 3 site increase was localized to focal increases in the boundary zones between major cerebral arteries (and corresponding to regions of ischaemic or haemorrhagic infarction). Focal cerebral ischaemia was studied in rats and mice. Subsequent to middle cerebral artery occlusion in normotensive (Wistar/Kyoto) and spontaneously hypertensive rats, the density of omega 3 sites in the ipsilateral hemisphere was markedly elevated, the increase being greater in the spontaneously hypertensive rats. The increases in omega 3 labelling in these two strains matched the absolute volumes of infarctions, determined previously. Middle cerebral artery occlusion in the mouse also increased hemispheric levels of omega 3 sites; the maximum values were obtained between 4 and 8 days following the induction of focal ischaemia. These results demonstrate the feasibility of using omega 3 sites as a marker of excitotoxic, ischaemic and proliferative damage in the rodent brain. Binding measurement in tissue homogenates is an economic and time-efficient approach, whereas the autoradiographic detection of omega 3 sites allows the localization of brain lesions with a macroscopic or microscopic level of anatomical resolution.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  J. Brierley,et al.  A New Model of Bilateral Hemispheric Ischemia in the Unanesthetized Rat , 1979, Stroke.

[2]  T. Brennan,et al.  GABA and benzodiazepine binding sites in spontaneously hypertensive rat. , 1983, European journal of pharmacology.

[3]  J. E. Vaughn,et al.  2 – Neuroglia in Experimentally Altered Central Nervous System1 , 1972 .

[4]  S. Amano Vascular changes in the brain of spontaneously hypertensive rats: Hyaline and fibrinoid degeneration , 1977, The Journal of pathology.

[5]  C. Petito Transformation of Postischemic Perineuronal Glial Cells. I. Electron Microscopic Studies , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Alan Peters,et al.  The effect of aging on the neuronal population within area 17 of adult rat cerebral cortex , 1983, Neurobiology of Aging.

[7]  Y. Ben-Ari,et al.  Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy , 1981, Neuroscience.

[8]  R. Horie Cerebral circulation and the initiation mechanism of stroke in stroke-prone spontaneously hypertensive rats (SHRSP). , 1977, Japanese circulation journal.

[9]  C. Petito,et al.  Early proliferative changes in astrocytes in postischemic noninfarcted rat brain , 1982, Annals of neurology.

[10]  S. Yamada,et al.  High affinity [3H]flunitrazepam binding: characterization, localization, and alteration in hypertension. , 1981, Life sciences.

[11]  Philippe Cornu,et al.  Imaging of human brain lesions with an ω3 site radioligand , 1988 .

[12]  D. Graham,et al.  Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  S. Z. Langer,et al.  Imidazopyridines as a tool for the characterization of benzodiazepine receptors: A proposal for a pharmacological classification as omega receptor subtypes , 1988, Pharmacology Biochemistry and Behavior.

[14]  R. Naquet,et al.  Evidence suggesting secondary epileptogenic lesions after kainic acid: pretreatment with diazepam reduces distant but not local brain damage , 1979, Brain Research.

[15]  B. Reisberg Alzheimer's Disease: The Standard Reference , 1983 .

[16]  G. Fur,et al.  Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization , 1983, Journal of neurochemistry.

[17]  J. Bénavidès,et al.  Cellular distribution of ω 3 (peripheral type benzodiazepine) binding sites in the normal and ischaemic rat brain: An autoradiographic study with the photoaffinity ligand [3H]PK 14105 , 1990, Neuroscience Letters.

[18]  C. Cotman,et al.  The distribution of [3H]kainic acid binding sites in rat CNS as determined by autoradiography , 1982, Brain Research.

[19]  B. Scatton,et al.  Inhibitory influence of GABA on central serotonergic transmission. Raphe´nuclei as the neuroanatomical site of the GABAergic inhibition of cerebral serotonergic neurons , 1985, Brain Research.

[20]  T. Sakamoto,et al.  Effect of Lactacidosis on Pyridine Nucleotide Stability During Ischemia in Mouse Brain , 1987, Journal of neurochemistry.

[21]  J. Coyle,et al.  Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea , 1976, Nature.

[22]  D. Duverger,et al.  Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat , 1988, Brain Research.

[23]  G. Le Fur,et al.  Photoaffinity labeling of peripheral-type benzodiazepine-binding sites. , 1987, Molecular pharmacology.

[24]  P. Worms,et al.  The behavioural effects of systemically administered kainic acid: a pharmacological analysis. , 1981, Life sciences.

[25]  A. Peters,et al.  The Structure of Neuritic Plaques in the Cerebral Cortex of Aged Rats , 1981, Journal of neuropathology and experimental neurology.

[26]  H. Schoemaker,et al.  [3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia , 1982, Brain Research.

[27]  K. Okamoto,et al.  Experimental studies on the pathogenesis and prophylaxis of stroke in stroke-prone spontaneously hypertensive rats (SHR).(1) Quantitative estimation of cerebrovascular permeability. , 1975, Japanese circulation journal.

[28]  K. Hossmann Treatment of Experimental Cerebral Ischemia , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  T. Crow,et al.  [3H]R05-4864 and [3H]flunitrazepam binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type , 1983, Brain Research.

[30]  D. Selkoe,et al.  Huntington's disease: Changes in striatal proteins reflect astrocytic gliosis , 1982, Brain Research.

[31]  Y. Ben-Ari,et al.  Limbic seizures induced by systemically applied kainic acid: how much kainic acid reaches the brain? , 1986, Advances in experimental medicine and biology.

[32]  P. Mcgeer,et al.  Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids , 1976, Nature.

[33]  Y. Yamori,et al.  Ultrastructural characteristics of occluded perforating arteries in stroke-prone spontaneously hypertensive rats. , 1987, Stroke.

[34]  E. Hamel,et al.  Omega 3 (peripheral type benzodiazepine binding) site distribution in the rat immune system: an autoradiographic study with the photoaffinity ligand [3H]PK 14105. , 1989, The Journal of pharmacology and experimental therapeutics.

[35]  E. Mackenzie,et al.  The pharmacotherapy of focal cortical ischaemia in the mouse , 1990, Brain Research.

[36]  D. W. Vaughan,et al.  Ultrastructure of neurons in the auditory cortex of ageing rats: a morphometric study , 1979, Journal of neurocytology.

[37]  Imaging of a glioma using peripheral benzodiazepine receptor ligands. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Coyle,et al.  Kainic acid neurotoxicity and seizures , 1981, Neuropharmacology.

[39]  Fred Plum,et al.  Temporal profile of neuronal damage in a model of transient forebrain ischemia , 1982, Annals of neurology.

[40]  J. Wamsley,et al.  Autoradiographic localization of high-affinity [3H]kainic acid binding sites in the rat forebrain. , 1983, European journal of pharmacology.

[41]  D. Duverger,et al.  Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. , 1988, The Journal of pharmacology and experimental therapeutics.

[42]  F. Zavala,et al.  Benzodiazepines and PK 11195 Exert Immunomodulating Activities by Binding on a Specific Receptor on Macrophages a , 1987, Annals of the New York Academy of Sciences.

[43]  D. Heggli,et al.  Systemic injection of kainic acid: Effect on neurotransmitter markers in piriform cortex, amygdaloid complex and hippocampus and protection by cortical lesioning and anticonvulsants , 1982, Neuroscience.

[44]  L. Lachman,et al.  Interleukin-1 stimulation of astroglial proliferation after brain injury. , 1985, Science.

[45]  P. Skolnick,et al.  CHARACTERIZATION OF BENZODIAZEPINE BINDING SITES IN CULTURED CELLS OF NEURAL ORIGIN , 1979, Journal of neurochemistry.

[46]  S. Kohsaka,et al.  Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats. , 1988, Brain research.

[47]  K. Okamoto,et al.  CHANGES IN VASCULAR PERMEABILITY IN THE BRAIN OF STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS STUDIED WITH PEROXIDASE AS A TRACER , 1975 .

[48]  G. L. Coleman,et al.  Pathological Changes During Aging in, Barrier-Reared Fischer 344 Male Rats1 , 1977, Journal of gerontology.

[49]  C. Pert,et al.  Benzodiazepine receptor-mediated chemotaxis of human monocytes. , 1985, Science.

[50]  D. Duverger,et al.  The Quantification of Cerebral Infarction following Focal Ischemia in the Rat: Influence of Strain, Arterial Pressure, Blood Glucose Concentration, and Age , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  C. Carter,et al.  Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage , 1987, Brain Research.

[52]  H. Schoemaker,et al.  Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney , 1981, Neurobiology of Aging.

[53]  R. Terry,et al.  Senile dementia of the Alzheimer type , 1983, Annals of neurology.

[54]  P. Steen,et al.  Drug therapy in brain ischaemia. , 1985, British journal of anaesthesia.